You really need to understand the way biotech companies work more. DNDN and APPA are not comparable at this point. DNDN will have the market solely cornered on its new drug. APPA will have competition on its latest drug. And the patient cost for the two drugs will vary greatly. DNDN's will cost much, much more; thus the reward has always been far greater.
Market Data 
Markets 
AI
